Altimmune Inc (ALT)
8.01
-0.89
(-10.00%)
USD |
NASDAQ |
May 17, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Altimmune Market Cap: 567.93M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 567.93M |
| May 16, 2024 | 631.03M |
| May 15, 2024 | 628.90M |
| May 14, 2024 | 554.46M |
| May 13, 2024 | 522.55M |
| May 10, 2024 | 511.91M |
| May 09, 2024 | 547.36M |
| May 08, 2024 | 507.66M |
| May 07, 2024 | 515.46M |
| May 06, 2024 | 521.84M |
| May 03, 2024 | 517.59M |
| May 02, 2024 | 509.76M |
| May 01, 2024 | 501.26M |
| April 30, 2024 | 464.39M |
| April 29, 2024 | 453.40M |
| April 26, 2024 | 514.73M |
| April 25, 2024 | 510.47M |
| April 24, 2024 | 501.97M |
| April 23, 2024 | 536.71M |
| April 22, 2024 | 529.62M |
| April 19, 2024 | 489.91M |
| April 18, 2024 | 488.49M |
| April 17, 2024 | 499.13M |
| April 16, 2024 | 533.16M |
| April 15, 2024 | 535.29M |
| Date | Value |
|---|---|
| April 12, 2024 | 566.48M |
| April 11, 2024 | 595.55M |
| April 10, 2024 | 567.90M |
| April 09, 2024 | 595.55M |
| April 08, 2024 | 610.44M |
| April 05, 2024 | 644.47M |
| April 04, 2024 | 631.00M |
| April 03, 2024 | 658.65M |
| April 02, 2024 | 663.26M |
| April 01, 2024 | 725.30M |
| March 28, 2024 | 721.71M |
| March 27, 2024 | 630.26M |
| March 26, 2024 | 613.24M |
| March 25, 2024 | 604.74M |
| March 22, 2024 | 643.73M |
| March 21, 2024 | 643.87M |
| March 20, 2024 | 660.13M |
| March 19, 2024 | 617.72M |
| March 18, 2024 | 641.75M |
| March 15, 2024 | 696.88M |
| March 14, 2024 | 708.54M |
| March 13, 2024 | 771.09M |
| March 12, 2024 | 768.26M |
| March 11, 2024 | 697.59M |
| March 08, 2024 | 734.34M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
23.47M
Minimum
Nov 19 2019
1.099B
Maximum
Sep 02 2022
365.05M
Average
370.42M
Median
Oct 28 2020
Market Cap Benchmarks
| Eli Lilly and Co | 731.81B |
| Amgen Inc | 167.62B |
| Pfizer Inc | 162.29B |
| Viking Therapeutics Inc | 7.388B |
| GlycoMimetics Inc | 19.30M |
Market Cap Related Metrics
| PS Ratio | 1141.07 |
| Price to Book Value | 3.284 |
| Price | 8.01 |
| Earnings Yield | -20.10% |